Are you a startup with an innovative solution for managing pain? The DayOne Accelerator is looking for startups like yours!
Apply now and get the chance to receive a package of funding and services, coaching and more. The three selected startups receive a support package worth up to €41.5K (45K CHF) each in funding and services. They will enter a 3-month acceleration programme in January 2022, with dedicated workshops, tailored 1:1 coaching, access to their top biopharma network and further resources.
Early bird bonus: Be one of the first 50 applicants and get a chance to pitch at the DayOne Conference on November 4, 2021.
The accelerator at a glance
DayOne provides a wide range of support for accelerator participants to scale up their businesses:
- Up to €41.5K (45K CHF) in funding and services for each company
- Tailored coaching and mentoring to meet the needs of each team
- Embedding the participating ventures in Europe’s strongest biotech ecosystem
- Access to the co-working spaces at one of their Switzerland Innovation Park Basel Area sites
The DayOne Accelerator services are free for the participants and no equity is taken.
DayOne’s track record
DayOne Accelerator supports innovative ventures that solve a wide range of healthcare challenges – from diagnosis, treatment and prevention to patient and caregiver communication and improvements for healthcare workers.
Since 2018, they have accelerated 20 digital health companies that together have a valuation of more than 60 million and more than 130 employees. They have helped these companies by providing funding and for building the teams, skills and connections needed to be successful.
Broader acceleration offering
Building on their success, the DayOne Accelerator has now expanded its offer for promising healthcare ventures, geographically and thematically.
Their newest vertical for tech ventures in medical robotics, virtual reality for healthcare and personalized medical technologies is based in the Canton of Jura, Switzerland’s microtech hotspot. Their nationwide ‘Innovation Booster’ vertical, empowered by Innosuisse, accelerates early digital health ventures, with a special focus on using academia to create patient-centered solutions with big pharma and startups. Acceleration programmes for both new verticals will start in early 2022.